12:00 AM
Oct 13, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Taxus Element Stent: Completed Phase III enrollment

Boston Scientific completed enrollment of 1,264 patients in a single-blind, international Phase III trial (Taxus Perseus Workhouse study) comparing Taxus Element Stent...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >